First Eagle Investment Management
Holding/activity history for Pacira BioSciences Inc. (PCRX)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price |
| 2024 Q1 | 0 | 0 | Sell 100.00% | 0.01 | |
| 2023 Q4 | 103,081 | 0.01 | Reduce 50.35% | 0.01 | $33.74 |
| 2023 Q3 | 207,632 | 0.02 | Reduce 15.00% | 0.00 | $30.68 |
| 2023 Q2 | 244,272 | 0.03 | Add 38.46% | 0.01 | $40.07 |
| 2023 Q1 | 176,425 | 0.02 | Add 112.53% | 0.01 | $40.81 |
| 2022 Q4 | 83,013 | 0.01 | Add 5.71% | 0.00 | $38.62 |
| 2022 Q3 | 78,531 | 0.01 | Add 12.47% | 0.00 | $53.19 |
| 2022 Q2 | 69,825 | 0.01 | Add 46.32% | 0.00 | $58.30 |
| 2022 Q1 | 47,721 | 0.01 | Add 92.18% | 0.00 | $76.32 |
| 2021 Q4 | 24,832 | 0.00 | Buy | 0.00 | $60.16 |